NORFLEX

Main information

  • Trade name:
  • NORFLEX 100 mg prolonged-release tablet
  • Dosage:
  • 100 mg
  • Pharmaceutical form:
  • prolonged-release tablet
  • Prescription type:
  • Prescription only
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • NORFLEX 100 mg prolonged-release tablet
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Orphenadrine (citrate)
  • Product summary:
  • Suitability for use in older adult patients Orphenadrini citras Avoid using in older persons. Anticholinergic. Slightly sedative. Significant adverse effects include xerostomia, constipation, dizziness, tachycardia, urinary difficulties, confusion and cognitive disporder. Weakens the efficacy of anti-Alzheimer`s drugs.

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 1495
  • Authorization date:
  • 09-02-2009
  • Last update:
  • 21-02-2018